No Detail Found!

Synergistic effects of traditional Chinese medicine and anti-VEGF therapy on diabetic retinopathy progression: Insights into pharmacological mechanisms and clinical outcomes

Author(s)
Xianlin Zhou Suizhou Hospital Affiliated Hubei Univeity of Medicine, Suizhou, China.
Lin Kong Suizhou Hospital Affiliated Hubei Univeity of Medicine, Suizhou, China.
Qihong Wu Department of Ophthalmology, Nanzhang County Traditional Chinese Medicine Hospital,Xiangyang,China
Abstract
This study investigated the effects of combining traditional Chinese medicine (TCM) with anti-VEGF therapy in diabetic retinopathy (DR) and diabetic macular edema (DME). A total of 119 cases with DME were divided into the anti-VEGF treatment group (n=56) and the combination treatment group, which received both anti-VEGF and TCM (n=63). At six months, the anti-VEGF group exhibited greater visual acuity improvement, while the combination group showed more significant reduction in macular thickness. Quality of life scores were higher in the combination group. Correlation analysis revealed a significant association between the combined therapy and enhancements in visual acuity and macular thickness. The addition of TCM to anti-VEGF therapy offers potential pharmacological benefits, supporting improved clinical outcomes in DME patients. These findings suggest a promising integrative approach for enhancing visual and quality of life outcomes in DR management. Future research should focus on investigating the long-term effects of combining TCM with anti-VEGF therapy, particularly in relation to sustained improvements in visual function and macular thickness. Additionally, exploring the specific pharmacological mechanisms by which TCM enhances anti-VEGF treatment efficacy could provide valuable insights into optimizing therapeutic strategies for DR patients.
Publication Details
Page(s) 931-938
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 3, Year: 2025

Request the full text from PASTIC

Keywords
Anti-VEGF, traditional Chinese medicine, Diabetic macular edema, diabetic retinopath
References
Ai X,Yu P,Hou Y,Song X,Luo J,Li N,Lai X,Wang X,Meng X .2020 .A review of traditional Chinese medicine on treatment of diabetic retinopathy and involved mechanisms. Biomed, 132 : 110852.
Azad R,Sinha S,Nishant P .2021 .Asymmetric diabetic retinopathy. Indian J. Ophthalmol., 69(11) : 3026-3034.
Azrad-Leibovich T,Zahavi A,Gohas MF,Brookman M,Barinfeld O,Muhsinoglu O,Michowiz S,Fixler D,Goldenberg-Cohen N .2022 .Characterization of diabetic retinopathy in two mouse models and response to a single injection of anti-vascular endothelial growth factor. Int. J. Mol. Sci, 24(1) : 324.
Bai J,Song Z,Li G,Dong L,Zhang C .2023 .Efficacy and safety of anti-vascular endothelial growth factor drugs for coats' disease treatment: A systematic review. J. Ocul. Pharmacol. Th., 39(7) : 418-429.
Cao Y,Xiong J,Guan X,Yin S,Chen J,Yuan S,Liu H,Lin S,Zhou Y,Qiu J,Wang D,Liu B,Zhou J .2023 .Paeoniflorin suppresses kidney inflammation by regulating macrophage polarization via KLF4-mediated mitophagy. , 116 : 154901.
Chan L,Lin SS,Chan F,Ng DS .2023 .Optimizing treatment for diabetic macular edema during cataract surgery. Front Endocrinol, 14 : 1106706.
Chandrasekaran PR,Madanagopalan VG,Narayanan R .2021 .Diabetic retinopathy in pregnancy - A review. Indian J. Ophthalmol., 69(11) : 3015-3025.
Chaudhary S,Zaveri J,Becker N J .2021 .Proliferative diabetic retinopathy (PDR). Dm-Dis. Mon., 67(5) : 101140.
Chen J,Wang H,Qiu W H .2023 .Intravitreal antivascular endothelial growth factor, laser photocoagulation, or combined therapy for diabetic macular edema: A systematic review and network metaanalysis. Front Endocrinol., 14 : 1096105.
Cicinelli MV,La Franca L,Berni A,Bottazzi L,Rabiolo A,Lattanzio R,Udaondo P,Bandello F P .2024 .Rate and associations of inner retinal thinning in eyes with retinal vein occlusion and regressed macular oedema. Eye, 38(1) : 138-144.
De Aguiar RB and de Moraes JZ .2019 .Exploring the immunological mechanisms underlying the antivascular endothelial growth factor activity in tumors. Front Immunol, 10 : 1023.
Dervenis P,Dervenis N,Smith JM,Steel DH JM .2023 .Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy. Cochrane Db. Syst. Rev., 5(5) : CD008214.
Dogra MR,Vinekar A .2023 .Role of anti-vascular endothelial growth factor (anti-vegf) in the treatment of retinopathy of prematurity: A narrative review in the context of middle-income countries. Pediatr Health Med T., 14 : 59-69.
Dong S,Zhang Y,Xie Y,Ouyang H,Zhou S,Shi J,Lu B,Mei X,Ji L X .2025 .Uncovering the potential mechanism and bioactive compounds of Salviae Miltiorrhizae Radix et Rhizoma in attenuating diabetic retinopathy. Phytomedicine, 139 : 156461.
Fan W,Zeng S,Wang X,Wang G,Liao D,Li R,He S,Li W,Huang J,Li X,Liu J,Li N,Hou S N .2024 .A feedback loop driven by H3K9 lactylation and HDAC2 in endothelial cells regulates VEGF-induced angiogenesis. Genome Biol, 25(1) : 165.
Fung TH,Patel B,Wilmot EG,Amoaku WM .2022 .Diabetic retinopathy for the non-ophthalmologist. Clin. Med, 22(2) : 112-116.
Ghamdi A .2020 .Clinical Predictors of Diabetic Retinopathy Progression; A Systematic Review. Curr. Diabetes Rev., 16(3) : 242-247.
Gurreri A,Pazzaglia A .2021 .Diabetic macular edema: State of art and intraocular pharmacological approaches. Adv. Exp. Med, 1307 : 375-389.
Hang A,Feldman S,Amin AP,Ochoa J,Park SS .2023 .Intravitreal anti-vascular endothelial growth factor therapies for retinal disorders. Pharmaceuticals-Base, 16(8) : 1140.
Hartnett ME .2020 .Retinopathy of prematurity: Evolving treatment with anti-vascular endothelial growth Factor. Am. J. Ophthalmol., 218 : 208-213.
Hashimoto Y,Okada A,Matsui H,Yasunaga H,Aihara M,Obata R M .2023 .Recent trends in anti-vascular endothelial growth factor intravitreal injections: A large claims database study in Japan. , 67(1) : 109-118.
Kaiser PK,Schmitz-Valckenberg MS,Holz FG .2022 .Anti-vascular endothelial growth factor biosimilars in ophthalmology. Retina-J. Ret. Vit. Dis., 42(12) : 2243-2250.
Kuriyama S,Yamada T,Matsuda A,Takahashi G,Iwai T,Takeda K,Ueda K,Miyasaka T,Yokoyama Y,Shinji S,Sonoda H,Ohta R,Yonaga K,Kanaka S,Yoshida H S .2022 .Biomarkers for anti-vascular endothelial growth factor drugs. Oncol. Lett., 24(6) : 463.
Li Y,Mitchell W,Elze T,Zebardast N T .2021 .Association between diabetes, diabetic retinopathy and glaucoma. Curr Diabetes Rep, 21(10) : 38.
Moon BH,Kim Y,Kim SY Y .2023 .Twenty years of anti-vascular endothelial growth factor therapeutics in neovascular age-related macular degeneration treatment. Int. J. Mol. Sci, 24(16) : 13004.
O'Dea D,Kokaua J,Wheadon M .1995 .SF-36 health status questionnaire. J. Epidemiol. Commun. H., 49(6) : 647.
Pandit S,Ho AC,Yonekawa Y .2023 .Recent advances in the management of proliferative diabetic retinopathy. Curr. Opin. Ophthalmol., 34(3) : 232-236.
Prince J,Kumar D,Ghosh A,Arevalo JF,Zhang AY .2023 .Surgical management of diabetic macular edema. Curr Diabetes Rep, 23(6) : 119-125.
Rao C,Hu R,Hu Y,Jiang Y,Zou X,Tang H,Chen X,He X,Hu G .2024 .Theoretical exploring of potential mechanisms of antithrombotic ingredients in danshenchishao herb-pair by network pharmacological study, molecular docking and zebrafish models. Chin Med-Uk, 19(1) : 100.
Rayess N and Mruthyunjaya P .2020 .Anti-vascular endothelial growth factor therapy for radiation retinopathy. Osli Retina, 51(4) : S44-S49.
Sabanayagam C,Banu R,Chee ML,Lee R,Wang YX,Tan G,Jonas JB,Lamoureux EL,Cheng CY,Klein B,Mitchell P,Klein R,Cheung C,Wong TY C .2019 .Incidence and progression of diabetic retinopathy: A systematic review. Lancet Diabetes Endo, 7(2) : 140-149.
Sadikan MZ,Abdul NN .2023 .Diabetic retinopathy: emerging concepts of current and potential therapy. N-S. Arch. Pharmacol., 396(12) : 3395-3406.
Sarohia GS,Nanji K,Khan M,Khalid MF,Rosenberg D,Deonarain DM,Phillips MR,Thabane L,Kaiser PK,Garg SJ,Sivaprasad S,Wykoff CC,Chaudhary V .2022 .Treat-and-extend versus alternate dosing strategies with anti-vascular endothelial growth factor agents to treat center involving diabetic macular edema: A systematic review and meta-analysis of 2,346 eyes. , 67(5) : 1346-1363.
Tan TE,Wong TY .2022 .Diabetic retinopathy: Looking forward to 2030. , 13 : 1077669.
Tatsumi T .2023 .Current Treatments for Diabetic Macular Edema. Int. J. Mol. Sci, 24(11) : 9591.
Tsao YC,Chen TY,Wang LA,Lee CC,Lee WA,Hsu SM,Lai CC,Shao SC,Hung JH,Lai EC .2023 .Acute kidney injury from intravitreal anti-vascular endothelial growth factor drugs: A systematic review and metaanalysis of randomized controlled trials. Biodrugs, 37(6) : 843-854.
Wong TY,Haskova Z,Asik K,Baumal CR,Csaky KG,Eter N,Ives JA,Jaffe GJ,Korobelnik JF,Lin H,Murata T,Ruamviboonsuk P,Schlottmann PG,Seres AI,Silverman D,Sun X,Tang Y,Wells JA,Yoon YH,Wykoff CC .2024 .Faricimab treat-and-extend for diabetic macular edema: Two-year results from the randomized phase 3 YOSEMITE and RHINE trials. Ophthalmology, 131(6) : 708-723.
Yang Z,Qi J,Ping D,Sun X,Tao Y,Liu C,Peng Y C .2022 .Salvia miltiorrhiza in thorax and abdomainal organ fibrosis: A review of its pharmacology. Front Pharmacol, 13 : 999604.
Yin L,Zhang D,Ren Q,Su X,Sun Z X .2020 .Prevalence and risk factors of diabetic retinopathy in diabetic patients: A community based cross-sectional study. Medicine, 99(9) : e19236.
Youngblood H,Robinson R,Sharma A,Sharma S A .2019 .Proteomic biomarkers of retinal inflammation in diabetic retinopathy. Int. J. Mol. Sci, 20(19) : 4755.
0

Citations

0

Downloads

91

Views